The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Funding of US Biomedical Research, 2003-2008
Open accessAbstract
CONTEXT: With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown. OBJECTIVE: To quantify funding of biomedical research in the United States from 2003 to 2008. DESIGN: Publicly available data were used to quantify funding from government (federal, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new drug and device approvals by the US Food and Drug Administration over the same period were also evaluated. MAIN OUTCOME MEASURES: Funding and growth rates by source; numbers of US Food and Drug Administration approvals. RESULTS: Biomedical research funding increased from $75.5 billion in 2003 to $101.1 billion in 2007. In 2008, funding from the National Institutes of Health and industry totaled $88.8 billion. In 2007, funding from these sources, adjusted for inflation, was $90.2 billion. Adjusted for inflation, funding from 2003 to 2007 increased by 14%, for a compound annual growth rate of 3.4%. By comparison, funding from 1994 to 2003 increased at an annual rate of 7.8% (P < .001). In 2007, industry (58%) was the largest funder, followed by the federal government (33%). Modest increase in funding was not accompanied by an increase in approvals for drugs or devices. In 2007, the United States spent an estimated 4.5% of its total health expenditures on biomedical research and 0.1% on health services research. CONCLUSION: After a decade of doubling, the rate of increase in biomedical research funding slowed from 2003 to 2007, and after adjustment for inflation, the absolute level of funding from the National Institutes of Health and industry appears to have decreased by 2% in 2008.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
It’s The Prices, Stupid: Why The United States Is So Different From Other Countries
Anderson, G. F., Reinhardt, U. E., Hussey, P. S., & Petrosyan, V. (2003) · Health Affairs · doi:10.1377/hlthaff.22.3.89 · Cited by 757
Stimulating the Adoption of Health Information Technology
Blumenthal, D. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0901592 · Cited by 725
Translational research: crossing the valley of death
Butler, D. (2008) · Nature · doi:10.1038/453840a · Cited by 712
Financial Anatomy of Biomedical Research
Moses, H., Dorsey, E. R., Matheson, D. H. M., & Thier, S. O. (2005) · JAMA · doi:10.1001/jama.294.11.1333 · Cited by 447
Self-citationPaul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Science Business: The Promise, the Reality and the Future of Biotech
Li, W. (1969) · Journal of Commercial Biotechnology · doi:10.5912/jcb219 · Cited by 340
Can science be a business? Lessons from biotech.
Pisano, G. P. (2006) · PubMed · Cited by 283
Pharmaceutical Industry Profile
(2005) · Good Design Practices for GMP Pharmaceutical Facilities · doi:10.1201/9780849398537-6 · Cited by 179
Pharmaceutical Economics and Policy
Weiss, L. D., & Schweitzer, S. O. (1998) · Journal of Public Health Policy · doi:10.2307/3343547 · Cited by 138
Developing A Center For Comparative Effectiveness Information
Wilensky, G. R. (2006) · Health Affairs · doi:10.1377/hlthaff.25.w572 · Cited by 134
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012) · Public Health Reports® · doi:10.1177/003335491212700103 · Cited by 1,241
Biomedical research: increasing value, reducing waste.
Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P. A., Salman, R. A.-S., Chan, A.-W., & Glasziou, P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62329-6 · Cited by 1,003
Laslett, L. J., Alagona, P., Clark, B. A., Drozda, J. P., Saldivar, F., Wilson, S. R., Poe, C., & Hart, M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.002 · Cited by 768
Industry sponsorship and research outcome
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub2 · Cited by 605
Metadata
- Authors
- Dorsey, E. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-13
- Volume
- 303
- Issue
- 2
- Pages
- 137
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2163623879
- Cited by
- 335
- References
- 14
- FWCI
- 33.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Funding of US Biomedical Research, 2003-2008. https://app.cochat.ai/papers/10.1001/jama.2009.1987
- The paper
- Dorsey, E. R. (2010). Funding of US Biomedical Research, 2003-2008. JAMA. https://doi.org/10.1001/jama.2009.1987
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.